10.07.2015 Views

Annual Report 2009 - Isagen

Annual Report 2009 - Isagen

Annual Report 2009 - Isagen

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

ANNUAL REPORT <strong>2009</strong> / ISAGEN S.A. E.S.P.18CHANGES TO GOODGOVERNANCE PRACTICESHandling conflicts of interestGiving heed to the recommendations of theevaluation conducted in 2008, which werereviewed by the Board’s Affairs Committee,the Board of Directors approved an adjustmentto the definition of conflicts of interestcontained in the Good Governance Code.The foundation for such change is that: (i)Conflict of interest does not only arise fromwork functions; (ii) Conflict of interest arisesnot only from decision-making, but also fromfactual circumstances that take away objectivity;(iii) Conflict of interest also arises whenacting through third parties.Additionally, the procedure for disclosure ofconflict was adjusted, including aspects notpreviously expressed, such as: (i) Whenevermanagement staff members are involved(CEO and Board of Directors Members), allowreporting of the conflict to the Boardthrough the General Secretary Office, andexclude involved Board Member from deliberationor decision-making regarding the solutionto conflict; (ii) When associates are involved,disclosure of conflict and reply fromthe superior by the same means (written evidence),to enable traceability; if the immediatesuperior is also involved in conflict, itmust be referred to the next higher superiorfor solution.Criteria applicable to trading of sharesUpon recommendation of the Board AffairsCommittee, the Board of Directors authorizedissuing of Resolution No. 112 of <strong>2009</strong>revoking Resolution 102 of 2008, aimed atregulating trading of shares and otherISAGEN securities by its Managers andAssociates. The new Resolution adjustedthe following aspects:(i) Definition of the concept of “speculation”,specifying it and separating theconcept of insider information.(ii) Obligation of every associate to NOTspeculate, and for ISAGEN Managersand Management Team members torequest authorization from Board ofDirectors to trade ISAGEN shares.(iii) Ratification of the duty to refrain fromusing insider information for tradingISAGEN shares, applicable to everyassociate.(iv) Application of provisions of section (iii)above, whenever trading bonds or domesticdebt bonds, being understoodthat their trading is not subject to requestof previous authorization providedfor in (ii) above, except when tradingconvertible bonds, in which case, regulationin force for trading of shareswould be applicable.(v) Non-applicability of the Resolution duringsale processes when these latter involveexercising a Preemptive Right orare conducted under general and uniformconditions, as is the case withthe processes under Law 226 of 1995and the Tender Offer included in theShareholders’ Agreement.Contents Letter from the CEO Achievements<strong>2009</strong>Good GovernancePractices EvaluationCorporateManagementFinancial Management

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!